Scientific article

English

Adverse events of raltegravir and dolutegravir

ContributorsElzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra

; Vernazza, Pietro; Günthard, Huldrych; Bernasconi, Enos; Battegay, Manuel

Published inAIDS, vol. 31, no. 13, p. 1853-1858

Publication date2017

Abstract

To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir.

Keywords

Adolescent
Adult
Aged
Aged
80 and over
Anti-HIV Agents/administration & dosage/adverse effects
Drug-Related Side Effects and Adverse Reactions/epidemiology
Female
HIV Infections/drug therapy
Heterocyclic Compounds
3-Ring/administration & dosage/adverse effects
Humans
Male
Mental Disorders/chemically induced/epidemiology
Middle Aged
Prospective Studies
Raltegravir Potassium/administration & dosage/adverse effects
Switzerland
Withholding Treatment
Young Adult

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

VIH/SIDA (930)

Citation (ISO format)

ELZI, Luigia et al. Adverse events of raltegravir and dolutegravir. In: AIDS, 2017, vol. 31, n° 13, p. 1853–1858. doi: 10.1097/QAD.0000000000001590

Article (Published version)

Identifiers

PID : unige:112378
DOI : 10.1097/QAD.0000000000001590
PMID : 28692533

Journal ISSN0269-9370

393views

153downloads

Creation06/11/2018 16:39:00

First validation06/11/2018 16:39:00

Update time15/03/2023 15:16:59

Status update15/03/2023 15:16:59

Last indexation31/10/2024 12:17:14